Guaifenesin 58602-0810-12
- Manufacturer
- Aurohealth Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- October 21, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA210453
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Selected Package
58602-0810-12Selected1 BOTTLE in 1 CARTON (58602-810-12) / 40 TABLET, EXTENDED RELEASE in 1 BOTTLE
Other packages for this product(6)
1 BOTTLE in 1 CARTON (58602-810-21) / 100 TABLET, EXTENDED RELEASE in 1 BOTTLE
8 BLISTER PACK in 1 CARTON (58602-810-38) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
1 BOTTLE in 1 CARTON (58602-810-73) / 20 TABLET, EXTENDED RELEASE in 1 BOTTLE
1 BLISTER PACK in 1 CARTON (58602-810-96) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
2 BLISTER PACK in 1 CARTON (58602-810-97) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
5 BLISTER PACK in 1 CARTON (58602-810-98) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK